FDA Advisory Panel Recommends Licensure of sanofi pasteurs ADACEL Vaccine for Combined Protection against Tetanus, Diphtheria and Pertussis
Vaccine Leader Looks to Introduce First Pertussis Booster for Both Adolescents and Adults in United States Sanofi pasteur, the vaccines business of the sanofi-aventis Group (NYSE: SNY), announced today that the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) voted unanimously to recommend licensure of ADACEL (Tetanus Toxoi